ID
42046
Descrizione
Study Type: Interventional Study Design: Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment Official Title: Therapy for Chronic Cold Agglutinin Disease: A Prospective, Non-Randomized Multi-Center Study Demonstrating the Efficacy of Terminal Complement Inhibition in Patients With Cold Agglutinin Disease Using Eculizumab EudraCT-Nummer 2009-01696697 ClinicalTrials.gov-Identifier NCT01303952 https://clinicaltrials.gov/ct2/show/NCT01303952 Genehmigung durch Frau Ose
collegamento
https://clinicaltrials.gov/ct2/show/NCT01303952
Keywords
versioni (3)
- 27/10/16 27/10/16 -
- 27/10/16 27/10/16 -
- 15/03/21 15/03/21 - Dr. rer. medic Philipp Neuhaus
Caricato su
15 marzo 2021
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
End period - Medications, Adverse Events, Transfusion History, Conclusion and Termination UK Essen Therapy of Chronic Cold Agglutinin Disease With Eculizumab NCT01303952
End period - Medications, Adverse Events, Transfusion History, Conclusion and Termination UK Essen Therapy of Chronic Cold Agglutinin Disease With Eculizumab NCT01303952
Similar models
End period - Medications, Adverse Events, Transfusion History, Conclusion and Termination UK Essen Therapy of Chronic Cold Agglutinin Disease With Eculizumab NCT01303952
C0013227 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0449961 (UMLS CUI [1,2])
C1879316 (UMLS CUI [1,2])
C1879316 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C2348570 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,2])